Skip to main content
. 2025 Oct 13;51(10):e107065. doi: 10.1136/rapm-2025-107065

Table 3. Criteria findings.

Clinical utility criteria N=248 Transparency criteria N=248
Problem base, n (%) Pre-registration, n (%)
 Full 38.0 (15.3) Full 99.0 (39.9)
 Partial 168.0 (67.7) Partial 63.0 (25.4)
 Absent 42.0 (16.9) Absent 86.0 (34.7)
Context placement, n (%) Public protocol, n (%)
 Full 192.0 (77.4) Full 25.0 (10.1)
 Partial 52.0 (21.0) Partial 3.0 (1.2)
 Absent 4.0 (1.6) Absent 220.0 (88.7)
Information gain, n (%) Adherence to protocol, n (%)
 Full 176.0 (71.0) Full 28.0 (11.3)
 Partial 0.0 (0.0) Partial 1.0 (0.4)
 Absent 72.0 (29.0) Absent 219.0 (88.3)
Pragmatism, n (%) Funding stated, n (%)
 Full 5.0 (2.0) Full 181.0 (73.0)
 Partial 6.0 (2.4) Partial 5.0 (2.0)
 Absent 237.0 (95.6) Absent 62.0 (25.0)
Patient centeredness, n (%) Conflicts of interest, n (%)
 Full 248.0 (100.0) Full 220.0 (88.7)
 Partial 0.0 (0.0) Partial 0.0 (0.0)
 Absent 0.0 (0.0) Absent 28.0 (11.3)
Value for money, n (%) Raw data, n (%)
 Full 0.0 (0.0) Full 3.0 (1.2)
 Partial 0.0 (0.0) Partial 0.0 (0.0)
 Absent 248.0 (100.0) Absent 245.0 (98.8)
Feasibility, n (%)
 Full 191.0 (77.0)
 Partial 1.0 (0.4)
 Absent 56.0 (22.6)